{"DataElement":{"publicId":"2902417","version":"1","preferredName":"Lymphoma Ann Arbor Staging System Stage","preferredDefinition":"The classification of severity/extent of lymphoma (Hodgkins and Non-Hodgkins) based on the Ann Arbor staging system which categorizes lymphoma into four stages based on anatomic lymph nodal group involvement.","longName":"LYMPH_ANNARB_STG","context":"NCI Standards","contextVersion":"1","DataElementConcept":{"publicId":"2902404","version":"1","preferredName":"Lymphoma Stage","preferredDefinition":"A malignant (clonal) proliferation of B- or T- lymphocytes which involves the lymph nodes, bone marrow and/or extranodal sites.  This category includes Non-Hodgkin's lymphomas and Hodgkin's lymphomas. -- 2003_The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body.","longName":"LYMPH_STG","context":"NCIP","contextVersion":"1","ObjectClass":{"publicId":"2475110","version":"1","preferredName":"Lymphoma","preferredDefinition":"A malignant (clonal) proliferation of B- or T- lymphocytes which involves the lymph nodes, bone marrow and/or extranodal sites.  This category includes Non-Hodgkin's lymphomas and Hodgkin's lymphomas. -- 2003","longName":"C3208","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lymphoma","conceptCode":"C3208","definition":"A malignant (clonal) proliferation of B- lymphocytes or T- lymphocytes which involves the lymph nodes, bone marrow and/or extranodal sites. This category includes Non-Hodgkin lymphomas and Hodgkin lymphomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"11901624-1EB2-3055-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-04-16","endDate":null,"createdBy":"SHIDED","dateCreated":"2006-04-16","modifiedBy":"ONEDATA","dateModified":"2006-04-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2224086","version":"1","preferredName":"Stage","preferredDefinition":"The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body.","longName":"C16899","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Neoplasm Stage","conceptCode":"C16899","definition":"The extent of a cancer in the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F63F1A4F-0A96-5494-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-05-03","endDate":null,"createdBy":"UMLLOADER_CAMOD","dateCreated":"2005-05-03","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008549","version":"1","preferredName":"Involvement and Extent of Disease","preferredDefinition":"indication of the presence and extent of disease.","longName":"INV_AND_EXT_OF_DZ","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22AA815-A017-5261-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6C9F2890-0CC8-3C66-E040-BB89AD435C35","latestVersionIndicator":"Yes","beginDate":"2009-06-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-06-18","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2902406","version":"1","preferredName":"Ann Arbor Lymphoma Staging System Stage","preferredDefinition":"Classification of severity/extent of lymphoma (Hodgkins and Non-Hodgkins) based on the Ann Arbor staging system categorizes lymphoma into four stages based on anatomic lymph nodal group involvement.","longName":"ANNARB_STG_SYS_STG","context":"NCIP","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"6","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"IIIB","valueDescription":"Stage IIIB","ValueMeaning":{"publicId":"3153859","version":"1","preferredName":"Stage IIIB","longName":"3153859","preferredDefinition":"Involvement of lymph node regions on both sides of the diaphragm with B symptoms: fevers, night sweats, weight loss","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9403EDA7-2993-EBE3-E040-BB89AD43794E","latestVersionIndicator":"Yes","beginDate":"2010-11-01","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-11-01","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9403EDA7-29AB-EBE3-E040-BB89AD43794E","beginDate":"2010-11-01","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-11-01","modifiedBy":"ONEDATA","dateModified":"2010-11-01","deletedIndicator":"No"},{"value":"IVB","valueDescription":"Stage IVB","ValueMeaning":{"publicId":"3153858","version":"1","preferredName":"Stage IVB","longName":"3153858","preferredDefinition":"Diffuse or disseminated involvement of one or more extralymphatic organs in conjunction with disease in distant site(s); Any involvement of the liver or bone marrow, or nodular involvement of the lungs without symptoms (asymptomatic) \r\nDiffuse or disseminated involvement of one or more extralymphatic organs in conjunction with disease in distant site(s); Any involvement of the liver or bone marrow, or nodular involvement of the lungs with B symptoms: fevers, night sweats, weight loss","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9403EDA7-2970-EBE3-E040-BB89AD43794E","latestVersionIndicator":"Yes","beginDate":"2010-11-01","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-11-01","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9403EDA7-2988-EBE3-E040-BB89AD43794E","beginDate":"2010-11-01","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-11-01","modifiedBy":"ONEDATA","dateModified":"2010-11-01","deletedIndicator":"No"},{"value":"IIB","valueDescription":"Stage IIB","ValueMeaning":{"publicId":"3153860","version":"1","preferredName":"Stage IIB","longName":"3153860","preferredDefinition":"Localized involvement of a single extralymphatic organ or site in association with regional lymph node involvement with or without involvement of other lymph nodes regions on the same side of the diaphragm with B symptoms: fevers, night sweats, weight loss","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9403EDA7-29B6-EBE3-E040-BB89AD43794E","latestVersionIndicator":"Yes","beginDate":"2010-11-01","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-11-01","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9403EDA7-29CE-EBE3-E040-BB89AD43794E","beginDate":"2010-11-01","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-11-01","modifiedBy":"ONEDATA","dateModified":"2010-11-01","deletedIndicator":"No"},{"value":"IB","valueDescription":"Stage IB","ValueMeaning":{"publicId":"3153861","version":"1","preferredName":"Stage IB","longName":"3153861","preferredDefinition":"Involvement of a single lymphatic site (i.e. nodal region, Waldeyer's ring, thymus or spleen) without symptoms (asymptomatic) \r\nInvolvement of a single lymphatic site (i.e. nodal region, Waldeyer's ring, thymus or spleen) with B symtoms: fevers, night sweats, weight loss","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9403EDA7-29D9-EBE3-E040-BB89AD43794E","latestVersionIndicator":"Yes","beginDate":"2010-11-01","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-11-01","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9403EDA7-29F1-EBE3-E040-BB89AD43794E","beginDate":"2010-11-01","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-11-01","modifiedBy":"ONEDATA","dateModified":"2010-11-01","deletedIndicator":"No"},{"value":"IA","valueDescription":"Stage IA","ValueMeaning":{"publicId":"3153862","version":"1","preferredName":"Stage IA","longName":"3153862","preferredDefinition":"Involvement of a single lymphatic site (i.e. nodal region, Waldeyer's ring, thymus or spleen) without symptoms (asymptomatic)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9403EDA7-29FC-EBE3-E040-BB89AD43794E","latestVersionIndicator":"Yes","beginDate":"2010-11-01","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-11-01","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9403EDA7-2A14-EBE3-E040-BB89AD43794E","beginDate":"2010-11-01","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-11-01","modifiedBy":"ONEDATA","dateModified":"2010-11-01","deletedIndicator":"No"},{"value":"IE","valueDescription":"Stage IE","ValueMeaning":{"publicId":"3153863","version":"1","preferredName":"Stage IE","longName":"3153863","preferredDefinition":"Localized involvement of a single extralymphatic organ or site in the absence of any lymph node involvement","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9403EDA7-2A1F-EBE3-E040-BB89AD43794E","latestVersionIndicator":"Yes","beginDate":"2010-11-01","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-11-01","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9403EDA7-2A38-EBE3-E040-BB89AD43794E","beginDate":"2009-06-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-11-01","modifiedBy":"ONEDATA","dateModified":"2010-11-01","deletedIndicator":"No"},{"value":"IIA","valueDescription":"Stage IIA","ValueMeaning":{"publicId":"3153864","version":"1","preferredName":"Stage IIA","longName":"3153864","preferredDefinition":"Involvement of two or more lymph node regions on the same side of the diaphragm without symptoms (asymptomatic)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9403EDA7-2A42-EBE3-E040-BB89AD43794E","latestVersionIndicator":"Yes","beginDate":"2010-11-01","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-11-01","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9403EDA7-2A5A-EBE3-E040-BB89AD43794E","beginDate":"2009-06-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-11-01","modifiedBy":"ONEDATA","dateModified":"2010-11-01","deletedIndicator":"No"},{"value":"IIE","valueDescription":"Stage IIE","ValueMeaning":{"publicId":"3153865","version":"1","preferredName":"Stage IIE","longName":"3153865","preferredDefinition":"Localized involvement of a single extralymphatic organ or site in association with regional lymph node involvement, with or without involvement of other lymph node regions on the same side of the diaphragm","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9403EDA7-2A65-EBE3-E040-BB89AD43794E","latestVersionIndicator":"Yes","beginDate":"2010-11-01","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-11-01","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9403EDA7-2A7E-EBE3-E040-BB89AD43794E","beginDate":"2009-06-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-11-01","modifiedBy":"ONEDATA","dateModified":"2010-11-01","deletedIndicator":"No"},{"value":"IIIA","valueDescription":"Stage IIIA","ValueMeaning":{"publicId":"3153866","version":"1","preferredName":"Stage IIIA","longName":"3153866","preferredDefinition":"Involvement of lymph node regions on both sides of the diaphragm without symptoms (asymptomatic)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9403EDA7-2A88-EBE3-E040-BB89AD43794E","latestVersionIndicator":"Yes","beginDate":"2010-11-01","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-11-01","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9403EDA7-2AA0-EBE3-E040-BB89AD43794E","beginDate":"2009-06-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-11-01","modifiedBy":"ONEDATA","dateModified":"2010-11-01","deletedIndicator":"No"},{"value":"IIIE","valueDescription":"Stage IIIE","ValueMeaning":{"publicId":"3153867","version":"1","preferredName":"Stage IIIE","longName":"3153867","preferredDefinition":"Involvement of lymph node regions on both sides of the diaphragm, which may also be accompanied by extralymphatic extension in association with adjacent lymph node involvement","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9403EDA7-2AAB-EBE3-E040-BB89AD43794E","latestVersionIndicator":"Yes","beginDate":"2010-11-01","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-11-01","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9403EDA7-2AC4-EBE3-E040-BB89AD43794E","beginDate":"2009-06-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-11-01","modifiedBy":"ONEDATA","dateModified":"2010-11-01","deletedIndicator":"No"},{"value":"IIIE,S","valueDescription":"Stage IIIE, S","ValueMeaning":{"publicId":"3153868","version":"1","preferredName":"Stage IIIE, S","longName":"3153868","preferredDefinition":"Involvement of lymph node regions on both sides of the diaphragm, with extralymphatic extension in association with adjacent lymph node and spleen involvement","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9403EDA7-2ACE-EBE3-E040-BB89AD43794E","latestVersionIndicator":"Yes","beginDate":"2010-11-01","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-11-01","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9403EDA7-2AE7-EBE3-E040-BB89AD43794E","beginDate":"2009-06-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-11-01","modifiedBy":"ONEDATA","dateModified":"2010-11-01","deletedIndicator":"No"},{"value":"IIIS","valueDescription":"Stage IIIS","ValueMeaning":{"publicId":"3153869","version":"1","preferredName":"Stage IIIS","longName":"3153869","preferredDefinition":"Involvement of lymph node regions on both sides of the diaphragm, with involvement of the spleen","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9403EDA7-2AF1-EBE3-E040-BB89AD43794E","latestVersionIndicator":"Yes","beginDate":"2010-11-01","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-11-01","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9403EDA7-2B0A-EBE3-E040-BB89AD43794E","beginDate":"2009-06-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-11-01","modifiedBy":"ONEDATA","dateModified":"2010-11-01","deletedIndicator":"No"},{"value":"IVA","valueDescription":"Stage IVA","ValueMeaning":{"publicId":"3153870","version":"1","preferredName":"Stage IVA","longName":"3153870","preferredDefinition":"Diffuse or disseminated involvement of one or more extralymphatic organs in conjunction with disease in distant site(s); Any involvement of the liver or bone marrow, or nodular involvement of the lungs without symptoms (asymptomatic)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9403EDA7-2B14-EBE3-E040-BB89AD43794E","latestVersionIndicator":"Yes","beginDate":"2010-11-01","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-11-01","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9403EDA7-2B2C-EBE3-E040-BB89AD43794E","beginDate":"2009-06-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-11-01","modifiedBy":"ONEDATA","dateModified":"2010-11-01","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008549","version":"1","preferredName":"Involvement and Extent of Disease","preferredDefinition":"indication of the presence and extent of disease.","longName":"INV_AND_EXT_OF_DZ","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22AA815-A017-5261-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2902405","version":"1","preferredName":"Ann Arbor Lymphoma Staging System Stage","preferredDefinition":"The Ann Arbor system classifies lymphoma into four stages based on anatomic lymph nodal group involvement. Disease confined to one nodal group or location defines stage I. Disease limited to one side of the diaphragm, (the muscle separating the chest from the abdomen), defines stage II. Stage III patients have disease on both sides of the diaphragm and stage IV patients once again have disseminated disease. Consideration of involvement of the liver, spleen, and bone marrow are also considered in this system. Finally, the stage is subdivided into categories of A and B depending on the presence of symptoms of itching, weight loss, fever, and night sweats. Those having symptoms receive the designation \"B\" and have a worse prognosis.:The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body.","longName":"C54179:C16899","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Ann Arbor Lymphoma Staging System","conceptCode":"C54179","definition":"The Ann Arbor system classifies lymphoma into four stages based on anatomic lymph nodal group involvement. Disease confined to one nodal group or location defines stage I. Disease limited to one side of the diaphragm, (the muscle separating the chest from the abdomen), defines stage II. Stage III patients have disease on both sides of the diaphragm and stage IV patients once again have disseminated disease. Consideration of involvement of the liver, spleen, and bone marrow are also considered in this system. Finally, the stage is subdivided into categories of A and B depending on the presence of symptoms of itching, weight loss, fever, and night sweats. Those having symptoms receive the designation \"B\" and have a worse prognosis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm Stage","conceptCode":"C16899","definition":"The extent of a cancer in the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6C9F2890-0CDC-3C66-E040-BB89AD435C35","latestVersionIndicator":"Yes","beginDate":"2009-06-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-06-18","modifiedBy":"ONEDATA","dateModified":"2009-06-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6C9F2890-0CED-3C66-E040-BB89AD435C35","latestVersionIndicator":"Yes","beginDate":"2009-06-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-06-18","modifiedBy":"REEVESD","dateModified":"2010-11-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008601","version":"1","longName":"C3D Domain","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811685","version":"1","longName":"CCR","context":"CCR"}]},{"publicId":"2182125","version":"1","longName":"CCR Implementation","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811673","version":"1","longName":"C3D","context":"CCR"}]},{"publicId":"2192345","version":"1","longName":"Data Standards","context":"NCIP","ClassificationSchemeItems":[{"publicId":"3461038","version":"1","longName":"Lymphoma (Includes Hodgkins)","context":"NCIP"},{"publicId":"2859963","version":"1","longName":"Standard CRFs","context":"NCIP"},{"publicId":"3434437","version":"1","longName":"Staging/Extent of Disease (by Disease)","context":"NCIP"}]},{"publicId":"3461150","version":"1","longName":"Staging","context":"NCIP","ClassificationSchemeItems":[{"publicId":"3461152","version":"1","longName":"Hematologic Staging","context":"NCIP"}]},{"publicId":"5635300","version":"1","longName":"Case Report Form (CRF) Modules","context":"NCI Standards","ClassificationSchemeItems":[{"publicId":"10000689","version":"1","longName":"Staging/Extent of Disease (by Disease)","context":"NCI Standards"}]}],"AlternateNames":[{"name":"LCC","type":"USED_BY","context":"LCC"},{"name":"AECC","type":"USED_BY","context":"AECC"},{"name":"CITN","type":"USED_BY","context":"CITN"},{"name":"PBTC","type":"USED_BY","context":"PBTC"},{"name":"OHSU Knight","type":"USED_BY","context":"OHSU Knight"},{"name":"LYMPH_ANNARB_STG","type":"USED_BY","context":"Alliance"},{"name":"CCR","type":"USED_BY","context":"CCR"}],"ReferenceDocuments":[{"name":"Ann Arbor Stage","type":"Preferred Question Text","description":"Ann Arbor Stage","url":null,"context":"NCI Standards"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Preferred Standard","id":"6CA0497D-42B7-CD1B-E040-BB89AD434375","latestVersionIndicator":"Yes","beginDate":"2009-06-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-06-18","modifiedBy":"HARTLEYG","dateModified":"2021-06-17","changeDescription":"Curated for the NCI caBIG CRF Harmonization Initiative, Disease Staging module","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}